happening now in the newsroom the members of congress have an expectation that we protect the capitol. i m confident with the plan we have in place. u.s. capitol police on high alert ahead of a far right rally today in support of the january 6 insurrection. we do have a unanimous 18 out of 18 who voted yes. fda vaccine advisers voting to recommend booster shots to those 65 and older and those at risk for severe illness. the next steps and why it changes the white house s initial plans. have you ever seen anything like this? nothing. thousands of migrants arriving at the southern borders. we ll take you to the border where officials are overwhelmed. mysterious deaths, drugs and insurance scheme. the tragic and twisted saga of a prom innocent south carolina attorney who police say hired a hit man on himself. we are really proud to share this experience with everyone. and the all civilian crew of the flight set to splash down this evening. what this means f
arose. with justice breyer expected to announce his retirement, president biden might just get that opportunity. tonight president biden confronting a major decision about the supreme court. justice stephen breyer expected to retire, paving the way for the president to nominate his replacement. there has been no announcement from justice breyer. let him make whatever statement he s going to make. i ll be happy to talk about it later. reporter: biden now getting the opportunity to fulfill this 2020 campaign promise. i m looking forward to making sure there s a black woman on the supreme court to make sure i committed that if i m elected president, have an opportunity to appoint someone to the courts, i ll appoint the first black woman to the courts. we are putting together a list of a group of african american women who are qualified and have the experience to be in the court. reporter: the white house reiterating today biden s position on this front remains unch
New study shows moderna s booster shot still offers protection against the variant after six months. we want to welcome our viewers around the united states and the world. i m wolf blitzer, and you re in the situation room. let s get right to the breaking news, justice stephen breyer deciding to retire from the u.s. supreme court giving president biden a chance to nominate his successor while democrats still control the u.s. senate. m.j. lee is joining us right now. this is a very significant development for the supreme court and for the biden administration. reporter: that s right, wolf. a supreme court vacancy is a huge moment for any sitting presidency and one of president biden s big campaign promises was to put a black woman on the supreme court if the opportunity
A new study shows the moderna booster shot is effective against the omicron variant for at least six months, but the antibodies do wane over time prompting the company to advance its omicron-specific booster to the next phase of clinical trials. let s discuss with the former cdc director dr. tom frieden. dr. frieden, what do you make of these results on its current booster shot? are you reassured? well, let s take the big picture here. it s really important sorry i m getting feedback on this. i don t know if you re hearing me okay. we re hearing you fine. the vaccines are working remarkably well as preventing severe disease and death.
It s crucially important that people who haven t yet started vaccinations, 60 million people in the u.s., get vaccinated. if you haven t gotten your booster, get your booster. get up to date with your vaccinations. bottom line, it s great that pharmaceutical companies are making new vaccines, but it s up to scientists and other doctors outside of the pharmaceutical industry to tell us whether we need them, when and how often. when do you think, dr. frieden, americans will start getting omicron-specific boosters? moderna is advancing that vaccine in the next phase in these clinical trials. i don t know if this will ever be approved for americans. really, i m disappointed that a company like moderna might be doing something like this and trying to adjust their market valuation by saying that many people may get this vaccine. maybe yes, maybe no.